Abcellera Biologics is trading 5.1% down at $5.38 today with no clear catalyst, extending a volatile week that has seen several sharp moves in both directions.
- The move appears idiosyncratic, as there are no fresh company-specific headlines, earnings reports, or analyst actions directly tied to this morning's decline.
- Broader U.S. indices are trading slightly mixed, suggesting the sell-off is not being driven by sector-wide events or macro trends.